Synthetic mRNA is indeed the highway for today’s therapeutics, whether you’re working on developing new drugs against cancer targets, or whether you aim to develop new vaccines, Covid-19 being one of them. So, how can you obtain your mRNA within just a few weeks, ready to explore these potential applications? Read on to see how we can help you achieve this.

As detailed in a separate post, bit.bio have developed a new, innovative technology named opti-ox™ to reprogram human stem cells with precise control of transcription factor expression through iPSC engineering .

Here we’ll be taking a closer look at the products already available for researchers. As the technology can be applied to generate many other mature cell types, more will be coming soon, including human skeletal myocytes, hepatocytes, immune cell types and other CNS cell types.

The first products developed using opti-ox™ are ioGlutamatergic Neurons and ioSkeletal Myocytes derived from hiPSCs, which are both available across Europe through tebu-bio. There will be more to follow…

To overcome current cell model limitations, bit.bio have developed a new, innovative technology to reprogram human stem cells with precise control of transcription factor expression through iPSC engineering .

You can already access this new technology now through tebu-bio in Europe!  But first, let’s take a look at the technology in detail. If you like, you can also discover the available products here.

Every type of cell has different membrane properties, meaning that transfection of your specific nucleic acid can become challenging.

To overcome transfection limitations, RJH Biosciences have developed a new range of transfection reagents to transfect mammalian cells with specific nucleic acids.

Access to this new technology now through tebu-bio in Europe!